Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
暂无分享,去创建一个
A Gray | A. Farmer | R. Holman | D. Mant | A. Gray | A. Farmer | A. Wade | J. Simon | D. French | A. Kinmonth | H. Neil | P. Yudkin | Neil Haw. | A. Craven | P Yudkin | D Mant | D P French | Alisha N. Wade | R R Holman | A J Farmer | A N Wade | J Simon | A Craven | L Goyder | A-L Kinmonth | H A W Neil | Alastair Gray | L. Goyder | David Mant | Patricia Yudkin | Rury R. Holman | Andrew Farmer | A. Wade | David P. French | Judit Simon | P. Yudkin | Alastair Gray | Anthea Craven | L. Goyder | Rury R Holman | A. N. Wade
[1] P F Sharp,et al. The value of digital imaging in diabetic retinopathy. , 2003, Health technology assessment.
[2] P Wainwright,et al. Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations. , 2004, Health technology assessment.
[3] M Forshaw,et al. A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment. , 1997, Health technology assessment.
[4] F. Schellevis,et al. The Efficacy of Self-Monitoring of Blood Glucose in NIDDM subjects: A criteria-based literature review , 1997, Diabetes Care.
[5] 農林水産奨励会農林水産政策情報センター,et al. The green book : appraisal and evaluation in central government , 2003 .
[6] C. Schmid,et al. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. , 2002, Diabetes care.
[7] Pd redaction. Oświadczenie w sprawie konfliktu interesów , 2001 .
[8] C. Bull,et al. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. , 2005, Health technology assessment.
[9] M. McDonagh,et al. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina. , 2000, Health technology assessment.
[10] A. Silman,et al. Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis. , 2004, Health technology assessment.
[11] C. Normand,et al. A systematic review of the role of bisphosphonates in metastatic disease. , 2004, Health technology assessment.
[12] A H Briggs,et al. Handling uncertainty when performing economic evaluation of healthcare interventions. , 1999, Health technology assessment.
[13] J. Weinman,et al. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. , 1999, Journal of psychosomatic research.
[14] M. Petticrew,et al. Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions. , 1998, Health technology assessment.
[15] C. Normand,et al. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. , 2000, Health technology assessment.
[16] T. Peters,et al. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. , 2001, Health technology assessment.
[17] L. Bouter,et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. , 2005, Diabetes care.
[18] P Drouin,et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. , 2003, Diabetes & metabolism.
[19] A. Thompson,et al. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. , 2004, Health technology assessment.
[20] A H Briggs,et al. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. , 1997, Health economics.
[21] R. Milne,et al. Disease-modifying drugs for multiple sclerosis: a rapid and systematic review. , 2000, Health technology assessment.
[22] A. Farmer,et al. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial , 2008, BMJ : British Medical Journal.
[23] N. Waugh,et al. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation. , 2004, Health technology assessment.
[24] P. Whiting,et al. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention. , 2001, Health technology assessment.
[25] David R. Jones,et al. Methods for the analysis of quality-of-life and survival data in health technology assessment. , 1999, Health technology assessment.
[26] Stephen Sutton,et al. A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation. , 2005, Health education research.
[27] J Cowan,et al. Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation. , 2003, Health technology assessment.
[28] S. Bryan,et al. Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. , 2002, Health technology assessment.
[29] C. Beverley,et al. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies. , 2005, Health technology assessment.
[30] P. Bower,et al. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care. , 2000, Health technology assessment.
[31] K Tolley,et al. The effectiveness of domiciliary health visiting: a systematic review of international studies and a selective review of the British literature. , 2000, Health technology assessment.
[32] R. Glasgow,et al. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. , 2000, Diabetes care.
[33] P Barton,et al. Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK. , 2005, Health technology assessment.
[34] S. Kaplan,et al. Self‐monitoring of blood glucose in non‐insulin‐treated diabetic patients: a longitudinal evaluation of its impact on metabolic control , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[35] D G Altman,et al. Indirect comparisons of competing interventions. , 2005, Health technology assessment.
[36] R. Holman,et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. , 1999, JAMA.
[37] M. Davidson,et al. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. , 2005, The American journal of medicine.
[38] Russell E. Glasgow,et al. Beliefs versus feelings: A comparison of personal models and depression for predicting multiple outcomes in diabetes , 2000 .
[39] J Gabbay,et al. 'Early warning systems' for identifying new healthcare technologies. , 1999, Health technology assessment.
[40] David R. Jones,et al. A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma. , 2003, Health technology assessment.
[41] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[42] A. Culyer,et al. False-negative results in screening programmes: systematic review of impact and implications. , 2000, Health technology assessment.
[43] Simon Finfer,et al. SAFE (The Saline versus Albumin Fluid Evaluation) 試験 , 2006 .
[44] M. Mugford,et al. Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views. , 2000, Health technology assessment.
[45] S. Martin,et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study , 2006, Diabetologia.
[46] Patrick Royston,et al. Multiple Imputation of Missing Values: Update of Ice , 2005 .
[47] C. Fowler,et al. Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia. , 2005, Health technology assessment.
[48] A Haycox,et al. Coronary artery stents: a rapid systematic review and economic evaluation. , 2004, Health technology assessment.
[49] M. Gulliford,et al. Variations in glucose self‐monitoring during oral hypoglycaemic therapy in primary care , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[50] Kingston H. Tseng,et al. Standards of Medical Care in Diabetes–2006 , 2006, Diabetes Care.
[51] K. Payne,et al. Which anaesthetic agents are cost-effective in day surgery? Literature review, national survey of practice and randomised controlled trial. , 2002, Health technology assessment.
[52] B. Cooper,et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. , 2003, Health technology assessment.
[53] A Haycox,et al. Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. , 2003, Health technology assessment.
[54] M. Smith,et al. Systematic review of endoscopic ultrasound in gastro-oesophageal cancer. , 1998, Health Technology Assessment.
[55] N. Waugh,et al. Screening for gestational diabetes: a systematic review and economic evaluation. , 2002, Health technology assessment.
[56] K. Jolly,et al. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. , 2000, Health technology assessment.
[57] C. Czoski-Murray,et al. Extended scope of nursing practice: a multicentre randomised controlled trial of appropriately trained nurses and pre-registration house officers in pre-operative assessment in elective general surgery. , 2001, Health technology assessment.
[58] J Chilcott,et al. A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative. , 2003, Health technology assessment.
[59] M. Harris,et al. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. , 2001, Diabetes care.
[60] M. Sculpher,et al. Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis. , 2005, Health technology assessment.
[61] S. Walters,et al. Costs and benefits of community postnatal support workers: a randomised controlled trial. , 2000, Health technology assessment.
[62] J Raftery,et al. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. , 2005, Health technology assessment.
[63] P. Royle,et al. Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system. , 2003, Health technology assessment.
[64] C. Clar,et al. Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation. , 2005, Health technology assessment.
[65] R. Glasgow,et al. Personal models of diabetes and their relations to self-care activities. , 1990, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[66] N. Waugh,et al. Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review. , 2000, Health technology assessment.
[67] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[68] S. Paisley,et al. Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation. , 2006, Health technology assessment.
[69] P. Royle,et al. Screening for hepatitis C among injecting drug users and in genitourinary medicine clinics: systematic reviews of effectiveness, modelling study and national survey of current practice. , 2002, Health technology assessment.
[70] J. Dretzke,et al. Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus. , 2004, Health technology assessment.
[71] M K Campbell,et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. , 2004, Health technology assessment.
[72] A. Culyer,et al. Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews. , 1998, Health technology assessment.
[73] T. Sheldon,et al. What role for statins? A review and economic model. , 1999, Health technology assessment.
[74] S. Heller,et al. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial , 2002, BMJ : British Medical Journal.
[75] P. Barry,et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. , 2001, Health technology assessment.
[76] R Garside,et al. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. , 2005, Health technology assessment.
[77] A. Bagnall,et al. Effectiveness and cost-effectiveness of acute hospital-based spinal cord injuries services: systematic review. , 2003, Health technology assessment.
[78] M Sculpher,et al. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. , 2005, Health technology assessment.
[79] T P Klassen,et al. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. , 2003, Health technology assessment.
[80] A. Culyer,et al. Liquid-based cytology in cervical screening: a rapid and systematic review. , 2000, Health technology assessment.
[81] R. Bergenstal,et al. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. , 2005, The American journal of medicine.
[82] M. Johnston,et al. Interventions to prevent weight gain: a systematic review of psychological models and behaviour change methods , 2000, International Journal of Obesity.
[83] S. Mason,et al. EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. , 2004, Health technology assessment.
[84] M Sculpher,et al. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. , 2004, Health technology assessment.
[85] M. Gulliford,et al. Monitoring blood glucose control in diabetes mellitus: a systematic review. , 2000, Health technology assessment.
[86] C. Eiser,et al. Quality-of-life measures in chronic diseases of childhood. , 2001, Health technology assessment.
[87] D. Symmons,et al. The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. , 2005, Health technology assessment.
[88] R. Murray,et al. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. , 2006, Health technology assessment.
[89] A. Jennings,et al. Health Belief Scales Developed Specifically for People with Tablet‐treated Type 2 Diabetes , 1990, Diabetic medicine : a journal of the British Diabetic Association.
[90] A. Grant,et al. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions. , 2005, Health technology assessment.
[91] P Sutcliffe,et al. Health technology assessment. , 1986, Israel journal of medical sciences.
[92] M Knapp,et al. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. , 2005, Health technology assessment.
[93] M. Knapp,et al. Home treatment for mental health problems: a systematic review. , 2001, Health technology assessment.
[94] J A Kanis,et al. Treatment of established osteoporosis: a systematic review and cost-utility analysis. , 2002, Health technology assessment.
[95] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[96] M. Pitt,et al. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. , 2008, Health technology assessment.
[97] E. Hamera,et al. Blood Glucose Self-Monitoring Usage and its Influence on Patients' Perceptions of Diabetes , 1984, The Diabetes educator.
[98] R. Fitzpatrick,et al. Issues in methodological research: perspectives from researchers and commissioners. , 2001, Health technology assessment.
[99] Keith Petrie,et al. The Revised Illness Perception Questionnaire (IPQ-R) , 2002 .
[100] E. Murphy,et al. Qualitative research methods in health technology assessment: a review of the literature. , 1998, Health technology assessment.
[101] P Royston,et al. Minim: allocation by minimisation in clinical trials , 2004 .
[102] Russell E. Glasgow,et al. Personal Models of Diabetes Among Older Adults: Relationship to Self-Management and Other Variables , 1995, The Diabetes educator.
[103] P. Roderick,et al. The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model. , 2003, Health Technology Assessment.
[104] G. Latham,et al. Goal Setting as a Strategy for Health Behavior Change , 1995, Health education quarterly.
[105] M. Westwood,et al. Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer. , 2004, Health technology assessment.
[106] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .
[107] M J Buxton,et al. Evaluating patient-based outcome measures for use in clinical trials. , 1998, Health technology assessment.
[108] J Nicholl,et al. Routine preoperative testing: a systematic review of the evidence. , 1997, Health technology assessment.
[109] S. Stearns,et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. , 2003, Health technology assessment.
[110] David R. Jones,et al. A systematic review of discharge arrangements for older people. , 2002, Health technology assessment.
[111] D. Spiegelhalter,et al. Consensus development methods, and their use in clinical guideline development. , 1998, Health technology assessment.
[112] A. Farmer,et al. Self‐monitoring of blood glucose changed non‐insulin‐treated Type 2 diabetes patients’ beliefs about diabetes and self‐monitoring in a randomized trial , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[113] R. Milne,et al. Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. , 2002, Health technology assessment.
[114] A. Knowles. DIABETIC FOOT ULCERATION , 1996 .
[115] R. Milne,et al. Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation. , 2002, Health technology assessment.
[116] R. Jordan,et al. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. , 2000, Health technology assessment.
[117] A. Culyer,et al. Newborn screening for inborn errors of metabolism: a systematic review. , 1997, Health technology assessment.
[118] A. Glenny,et al. Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials , 1998, Health technology assessment.
[119] J Gabbay,et al. Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. , 2004, Health technology assessment.
[120] F. Song,et al. Evaluating non-randomised intervention studies. , 2003, Health technology assessment.
[121] D. Aronson,et al. Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarction , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[122] M. Mugford,et al. The Social Support and Family Health Study: a randomised controlled trial and economic evaluation of two alternative forms of postnatal support for mothers living in disadvantaged inner-city areas. , 2004, Health technology assessment.
[123] M. Drummond,et al. Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .
[124] S. Paisley,et al. Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review. , 2003, Health technology assessment.
[125] R. Holman,et al. A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) , 2004, Diabetologia.
[126] S. Palmer,et al. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation. , 2006, Health Technology Assessment.
[127] T. Davis,et al. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study , 2007, Diabetologia.
[128] M. Pitt,et al. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. , 2005, Health technology assessment.
[129] D. A. Kenny,et al. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.
[130] M. Pitt,et al. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. , 2006, Health technology assessment.
[131] S. Ebrahim,et al. Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups. , 2004, Health technology assessment.
[132] R. Collins,et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. , 2005, Health technology assessment.
[133] A. Round,et al. Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis. , 2004, Health technology assessment.
[134] A E Ades,et al. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. , 1999, Health technology assessment.
[135] M. Chin,et al. Considerations for diabetes translational research in real-world settings. , 2003, Diabetes care.
[136] M. Davidson,et al. Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. , 2005, Diabetes care.
[137] G. ter Riet,et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. , 2008, Health technology assessment.
[138] J. Wight,et al. Treatments for spasticity and pain in multiple sclerosis: a systematic review. , 2003, Health technology assessment.
[139] Jennifer A. Roberts,et al. Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. , 2006, Health technology assessment.
[140] M. Gulliford,et al. Self‐monitoring in Type 2 diabetes mellitus: a meta‐analysis , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[141] Barbara Resnick,et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. , 2004, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[142] T. Skinner,et al. Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. , 2001, Health technology assessment.
[143] D. Lamping,et al. An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales. , 2005, Health technology assessment.
[144] F. Cowan,et al. Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness. , 2000, Health technology assessment.
[145] J. Gerich. Clinicians Can Help Their Patients Control Postprandial Hyperglycemia as a Means of Reducing Cardiovascular Risk , 2006, The Diabetes educator.
[146] A. Grant,et al. Systematic review of the clinical effectiveness and cost-effectiveness of tension-free vaginal tape for treatment of urinary stress incontinence. , 2003, Health technology assessment.
[147] S. Wessely,et al. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. , 2002, Health technology assessment.
[148] G. Mertes,et al. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. , 2002, Diabetes care.
[149] I. Hirsch,et al. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. , 2002, Diabetes care.
[150] K. Morgan,et al. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. , 2004, Health technology assessment.
[151] E Berry,et al. The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review. , 2002, Health technology assessment.
[152] D. Symmons,et al. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling. , 2006, Health technology assessment.
[153] P. Gard. A behavioural approach to pharmacy practice , 2000 .
[154] C Fraser,et al. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation. , 2005, Health technology assessment.
[155] M Sculpher,et al. Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation. , 2004, Health technology assessment.